Bayer is launching a dynamic Institutional & Specialty Sales team to bring Asundexian, a next-generation stroke prevention therapy, to market. This role offers a rare opportunity to shape access, accelerate clinical adoption, and play a pivotal role in a high-profile neurology launch, delivering innovation to patients when it matters most. The role will cover the geography of Des Moines, Iowa, and candidates must be domiciled within the territory. This is an extraordinary opportunity to be part of a new team launching Asundexian, an oral Factor XIa inhibitor. Bayer was named one of Fast Company magazine’s Most Innovative companies in Medicines and Therapeutics in 2026. The company is committed to investing in digital tools to allow the team to work smarter and to harness the power of AI.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior